In addition to loss of Numb, Notch1 gain-of-function mutations are found in approximately 10% of all NSCLC patients, which localize to the heterodimerization, transactivation, and PEST domain of Notch1 [43]. The gene discussed is NOTCH1; the disease is non-small cell lung carcinoma.